RNA-seq of human NSCLCL treated with Alectinib, Lorlatinib or Brigatinib

ABSTRACT: RNA-seq of human NSCLCL treated with Alectinib, Lorlatinib or Brigatinib

PROVIDER: PRJEB50324 | ENA |

REPOSITORIES: ENA